Presenting the AliveDx 2023 Sustainability Report

At AliveDx, we understand that the success of our business is closely linked to the wellbeing of the communities in which we operate. Our goal is to advance sustainable practices in every aspect of our operations. We are pleased to present the AliveDx 2023 Sustainability Report as a testament to our dedication.

The 2023 Sustainability Report derives its framework from the UN Sustainable Development Goals (SDGs). It details our global social, environmental, and governance initiatives, which cover a variety of subjects, including waste management, renewable energy sources, site health and safety, as well as product quality and safety controls.

Please also feel free to visit the Environmental, Social & Governance Commitments section of our website.

Trending Topics

Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.

March 26, 2024

AliveDx Suisse S.A. and Ozgun Kimya A.S. Sign Distribution Agreement in Türkiye

AliveDx Suisse S.A. and Ozgun Kimya A.S. have signed a distribution agreement, which will enable Ozgun Kimya A.S. to distribute the MosaiQ® solution in Türkiye. The distribution agreement takes effect immediately. This strategic partnership reaffirms AliveDx’s consistent commitment to grow
March 25, 2024

MosaiQ® AiPlex CTD Solution Now Available in Over 35 Countries

We are excited to announce that our recently CE-marked MosaiQ® AiPlex CTD microarray immunoassay, which aims to shorten time-to-diagnosis for autoimmune patients, is now available in over 35 markets across Europe and the Asia Pacific region. The MosaiQ AiPlex CTD
February 2, 2024

Bringing AliveDx’s ESG Activities and Commitments to Life

Our leadership team recently gathered to celebrate 2023 achievements and kick off the new year. As part of a highly energizing team-building activity, and to bring our environmental, social and governance commitments to life, the team built solar lamps that
January 4, 2024

MosaiQ abstract published in Immunochemistry & Immunopathology Journal

We are excited to share that our publication on the performance characteristics of our automated planar microarray immunoassay for the detection of antibodies against Centromere Protein B is now available in Immunochemistry & Immunopathology: https://www.hilarispublisher.com/open-access/performance-characteristics-of-a-novel-fully-automated-planar-microarray-immunoassay-for-the-detection-of-antibodies-against-centr-103431.html Would you like to know
December 12, 2023

AliveDx and Global Marketing Services sign distribution agreements for Pakistan

AliveDx and Global Marketing Services (GMS) have signed distribution agreements, which will enable Global Marketing Services to distribute MosaiQ® and Alba products in Pakistan. The distribution agreements take effect immediately. This strategic partnership acts as a reminder of AliveDx’s commitment
December 7, 2023

MosaiQ® Abstract Presented at APLAR 2023

We are excited to announce that our abstract titled “Performance of a Novel, Fully-automated Multiplexed Immunoassay Microarray Prototype for Serological Detection of Eleven Autoantibodies Found in Connective Tissue Diseases” will be presented at the 25th Asia-Pacific League of Associations for